Human PlasmaDerived Therapeutics Market
Human Plasma-Derived Therapeutics Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Human Plasma-Derived Therapeutics Market Size and Growth
The Human Plasma-Derived Therapeutics market is experiencing significant growth, driven by increasing demand for immunoglobulin therapies and advancements in plasma collection technologies. The global market size is projected to reach approximately $40 billion by 2027, with a CAGR of around 8% due to rising healthcare needs and improved access to treatments.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Alkahest
◍ Baxter
◍ CSL Behring
◍ Entegrion, Inc.
◍ Gammagard
◍ Grifols
◍ Kedrion
◍ Octapharma
◍ Prometic Life Sciences
◍ Sanquin
◍ Takeda
The Human Plasma-Derived Therapeutics Market features key players like Baxter, CSL Behring, and Takeda, leveraging innovative therapies for conditions such as immune deficiencies. Companies like Grifols and Octapharma enhance growth through product development and strategic partnerships. Select revenue figures include:
- Baxter: $12 billion
- CSL Behring: $10 billion
- Grifols: $6.5 billion.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Research Center
Request Sample Report
By Product
Albumin
Immunoglobulin
Clotting Factor
Prothrombin Complex
Others
Market Growth
Request Sample Report
$ X Billion USD
